Search
Treatment Settings
Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
UNODC Keeps Supporting Quality Drug Treatment Service via Continuous Capacity Building
UNODC Regional Office for Central Asia supported regional training of trainers (ToT) on Course 11 “Enhancing Motivational Interviewing Skills”. This course is part of the Advanced Level of the Universal Treatment Curriculum for Substance...
Online Echo Training on Motivational Interviewing for Children with Substance Use Disorders
Young children are now living in drug-life circumstances and are actively engaged in drug-using behavior. Recent data show that incidence and prevalence rates of substance use and substance use disorders among young children are increasing...
Drug Treatment and Management Training in Prison Inaugurated
Drug use has been identified as one of the ominous problems that the society faces now-a-days. Every drug dependent person has different and complex difficulties to go through in the process of recovering from such harmful behavior. Person...
WHO Quitting Toolkit
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
Quality Assurance (QA) of the Drug Treatment Services in Pakistan
Implementing brief advice for reducing alcohol and tobacco use at the first level of care: A qualitative study
Introduction: In Mexico the consumption of tobacco and alcohol represents a public health problem. Models of screening, brief intervention and referral to treatment (SBIRT) have shown efficacy in reducing such consumption, so they are used...
Fenacetina: Un Adulterante Tóxico Encontrado en Drogas Callejeras Ilegales
Las personas encargadas del tratamiento por abuso de sustancias, quienes ejercen la medicina clínica, los/las extensionistas, las clínicas de salud pública, entre otros, deben conocer la información que se detalla a continuación. La...
Call for Papers: New Drug and other Behavioural Trends During Social-Distancing for the COVID-19 Pandemic
This Special Issue explores new drug and behavioural trends during the Covid-19 Pandemic. We welcome multidisciplinary contributions aimed at enhancing the understanding of how “physical distancing” and other radical changes in our...
Mindfulness-Oriented Recovery Enhancement Remediates Hedonic Dysregulation in Opioid Users: Neural and Affective Evidence of Target Engagement
Abstract
Addiction neuroscience models posit that recurrent drug use increases reactivity to drug-related cues and blunts responsiveness to natural rewards, propelling a cycle of hedonic dysregulation that drives addictive behavior. Here...
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial
Abstract
Importance: Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine.
Objective: To compare patient satisfaction between...
The “Black Box” of Treatment: Patients’ Perspective on What Works in Opioid Maintenance Treatment for Opioid Dependence
Staff experiences of encountering and treating outpatients with substance use disorder in the psychiatric context: a qualitative study
Abstract
Background
High comorbidity exists between mental illness and substance use disorders (SUD). Patients in psychiatry living with problematic alcohol or drug consumption can experience a sense of exclusion, where seeking help for...
Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample
Recent studies suggest that the endocannabinoid system could play an important role in the physiopathology of obsessive-compulsive disorder (OCD). There are reports of effective treatment with derivatives of tetrahydrocannabinol (THC). The...
The NIDA Clinical Trials Network: Evolving, Expanding, and Addressing the Opioid Epidemic
Abstract
Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a nationwide consortium...
Addressing Unprecedented Challenges in Management of SUD’s and GBV in the midst of COVID-19
I National meeting of professionals in prevention and treatment of addictions
HIV/HCV prevalence and risk behavior among NPS users are a growing public health burden
On April 27, 2021, UNODC Regional Office for Central Asia held a training seminar for specialists of the republican and regional levels responsible for drug dependence treatment and HIV prevention services in the Republic of Uzbekistan. The...
Canadian Guidelines on Alcohol Use Disorder Among Older Adults
Open Access article:
Abstract
Background
Alcohol use disorder (AUD) is an increasingly common, under-recognized, and under-treated health concern in older adults. Its prevalence is expected to reach unprecedented levels as the Canadian...
Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member